Optimizing the use of parenteral iron in end-stage renal disease patients: focus on issues of infection and cardiovascular disease. Introduction.
Owen
W F
WF
Duke Institute of Renal Outcomes, Research and Health Policy, Durham, North Carolina, USA.
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007505:Iron-Dextran Complex / Q000008:administration & dosage* / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications*; D017410:Practice Guidelines as Topic
D007505:Iron-Dextran Complex